< Back to previous page
Project
Exploring the anti-inflammatory potential of Rothia mucilaginosa in chronic lung diseases.
In this project, we will confirm the anti-inflammatory effects of Rothia mucilaginosa in complex and physiologically relevant in vitro models of CF and COPD lung inflammation, as well as in in vivo mouse models. The anti-inflammatory compound(s) produced by this bacterium will be identified and the mode of action unveiled.
Date:1 Jan 2019 → 31 Dec 2022
Keywords:COPD, BACTERIOLOGY
Disciplines:Bacteriology
Project type:Collaboration project